FDA's AI Risk -Based Guidance Shifts Validation Burden to Sponsors
FDA's AI Risk -Based Guidance shifts validation burden to sponsors, requiring documented credibility assessments before deploying AI in clinical ...
The Clinical Trial Vanguard 5
Covers: HealthcareAI Agents & AutomationRegulation & PolicyHallucinations & Fabrication
Benchmarks Don't Fail Silently. Agentic AI Does. - The Clinical Trial Vanguard
Cassandra Chuljian, LinkedIn post on silent AI failure modes in regulated industries · Sumant Ranji, LinkedIn post on AI quality measurement and ...
Ambient AI Is Not Losing Your Trial Data. It's Quietly Deciding What Counts.
But they are aimed at the wrong target. The loudest version of the fear, that ambient AI will hallucinate information and fabricate clinical facts, is ...
Your AI Scored 92% on the Medical Exam. That Number Is Lying to You.
Health AI acing benchmarks while failing real clinical tasks exposes a ... failure to the end user. The hazard profile describes exactly what ...
When Bad Protocol Design Hits Your Site, AI Won't Save You - The Clinical Trial Vanguard
Four more screen failures later, the sponsor submits an amendment. The protocol amendment triggers a central IRB resubmission, an average of 21 days ...